First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Status:
Completed
Trial end date:
2015-08-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if Cediranib in combination with FOLFOX is effective in
treating metastatic colorectal cancer and to see how it compares with Avastin (Bevacizumab)
in combination with FOLFOX.